Science Explorer Back to mapMap
Discussion
Researcher · Abbott Fund · United States

Keith B. Glaser

Keith B. Glaser publishes mostly in Molecular Biology, Oncology and Hematology, on topics such as Histone Deacetylase Inhibitors Research, Protein Degradation and Inhibitors and Microtubule and mitosis dynamics.

OpenAlex
World rank
#795,387
of 7,710,434 ranked researchers
Rank in United States
#265,617
of 1,627,098
Works
149
Citations
6.7k
Citations per work
44.8
h-index
42
i10-index 79Top 6.3% in Molecular Biology
Keith B. Glaser

What does Keith B. Glaser research?

Keith B. Glaser's work is mostly in Biochemistry, Genetics and Molecular Biology (31%), Medicine (19%), Chemistry (5%).

Everything else: 59 works · 39.8% of their workLife Sciences: 54 works · 36.2% of their workBiochemistry, Genetics and Molecular Biology: 47 works · 31.3% of their workMolecular Biology: 40 works · 26.7% of their workCancer Research: 7 works · 4.6% of their workImmunology and Microbiology: 7 works · 4.9% of their workImmunology: 7 works · 4.9% of their workHealth Sciences: 28 works · 18.9% of their workMedicine: 28 works · 18.9% of their workOncology: 15 works · 10.0% of their workHematology: 13 works · 8.9% of their workPhysical Sciences: 8 works · 5.1% of their workChemistry: 8 works · 5.1% of their workOrganic Chemistry: 8 works · 5.1% of their workTHEIR WORKKeith B. Glaser149works
Life Sciences36%Physical Sciences5%Health Sciences19%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else5939.8%
    1. Biochemistry, Genetics and Molecular Biology4731.3%
    2. Immunology and Microbiology74.9%
    1. Medicine2818.9%
    1. Chemistry85.1%
  1. 1Molecular Biology27% of their works
  2. 2Oncology10% of their works
  3. 3Hematology9% of their works
  4. 4Organic Chemistry5% of their works
  5. 5Immunology5% of their works
  6. 6Cancer Research5% of their works

Research topics

Which keywords describe Keith B. Glaser's research?

The keywords of their largest research topics: Cancer Therapy, Mutation, HDAC Inhibitors, Histone Deacetylases, BET Bromodomains, PROTACs, Acute Myeloid Leukemia and AML.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Cancer Therapy443 topics
  2. Mutation222 topics
  3. HDAC Inhibitors201 topic
  4. Histone Deacetylases201 topic
  5. BET Bromodomains171 topic
  6. PROTACs171 topic
  7. AML151 topic
  8. Acute Myeloid Leukemia151 topic
  9. Cell Division151 topic
  10. Microtubules151 topic
  11. BCR-ABL131 topic
  12. Imatinib131 topic
  13. Biomedical Science91 topic
  14. Cell Cycle91 topic
  15. Cyclooxygenase-2 Inhibitors91 topic
  16. Health Research91 topic
  17. Inflammation91 topic
  18. p5391 topic

Where does Keith B. Glaser work?

Keith B. Glaser's main affiliation in the publication record is Abbott Fund, United States.

How many publications and citations does Keith B. Glaser have?

OpenAlex counts 149 works and 6,679 citations for Keith B. Glaser, an h-index of 42, ranking #795,387 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Keith B. Glaser. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.